(Q45401946)

English

Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years (English)

1 reference

Europe PubMed Central

14 December 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

2

object named as

Junko Tanaka

1 reference

Europe PubMed Central

14 December 2017

author name string

Masaaki Mizui

1

1 reference

Europe PubMed Central

14 December 2017

Keiko Katayama

3

1 reference

Europe PubMed Central

14 December 2017

Toshio Nakanishi

4

1 reference

Europe PubMed Central

14 December 2017

Makoto Obayashi

5

1 reference

Europe PubMed Central

14 December 2017

Shiomi Aimitsu

6

1 reference

Europe PubMed Central

14 December 2017

Tomoo Yoshida

7

1 reference

Europe PubMed Central

14 December 2017

Junichi Inoue

8

1 reference

Europe PubMed Central

14 December 2017

Tatsuji Yokoyama

9

1 reference

Europe PubMed Central

14 December 2017

Keiji Tsuji

10

1 reference

Europe PubMed Central

14 December 2017

Keiko Arataki

11

1 reference

Europe PubMed Central

14 December 2017

Syuji Yamaguchi

12

1 reference

Europe PubMed Central

14 December 2017

Toshio Miura

13

1 reference

Europe PubMed Central

14 December 2017

Mikiya Kitamoto

14

1 reference

Europe PubMed Central

14 December 2017

Eiichi Takezaki

15

1 reference

Europe PubMed Central

14 December 2017

Shigeo Orimen

16

1 reference

Europe PubMed Central

14 December 2017

Tatsurou Sakata

17

1 reference

Europe PubMed Central

14 December 2017

Kouji Kamada

18

1 reference

Europe PubMed Central

14 December 2017

Akira Maruhashi

19

1 reference

Europe PubMed Central

14 December 2017

Tooru Tamura

20

1 reference

Europe PubMed Central

14 December 2017

Toshio Nakamura

21

1 reference

Europe PubMed Central

14 December 2017

Kunio Ishida

22

1 reference

Europe PubMed Central

14 December 2017

Kazushi Teramen

23

1 reference

Europe PubMed Central

14 December 2017

Yuzo Miyakawa

24

1 reference

Europe PubMed Central

14 December 2017

Hiroshi Yoshizawa

25

1 reference

Europe PubMed Central

14 December 2017

publication date

11 July 2007

1 reference

Europe PubMed Central

14 December 2017

Hepatology Research

1 reference

Europe PubMed Central

14 December 2017

37

1 reference

Europe PubMed Central

14 December 2017

12

1 reference

Europe PubMed Central

14 December 2017

994-1001

1 reference

Europe PubMed Central

14 December 2017

The scientific challenge of hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

The natural history of hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

The natural history of hepatitis C virus (HCV) infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Course and outcome of hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Natural history of chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Hepatitis C infection in African Americans: its natural history and histological progression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Natural histories of hepatitis C virus infection in men and women simulated by the Markov model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany--a 25-year multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Outcomes of interferon and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Viral hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00157.X

21 January 2018

Identifiers

10.1111/J.1872-034X.2007.00157.X

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45401946&oldid=2076624359"